You Searched For: 5-Phenyl-1H-pyrazolo[3,4-c]pyridazin-3-ylamine


57,391  results were found

SearchResultCount:"57391"

Sort Results

List View Easy View

Rate These Search Results

Supplier: Apollo Scientific
Description: 5-Phenyl-1H-pyrazolo[3,4-c]pyridazin-3-ylamine

Supplier: Apollo Scientific
Description: 1-Methyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine

New Transparency for European Customers

Have you noticed our new improved visibility on stock location at checkout?

Find out more

Enhancement to stock locations

Supplier: Apollo Scientific
Description: 4,6-Dimethyl-1H-pyrazolo[3,4-b]pyridin-3-ylamine

Supplier: Apollo Scientific
Description: 1-Methyl-1H-pyrazolo[3,4-b]pyridin-3-ylamine 97%

Supplier: Apollo Scientific
Description: 1H-Pyrazolo[3,4-d]pyrimidin-4-amine 95%

Supplier: Apollo Scientific
Description: MAPK/ERK Signalling Pathway

Catalog Number: (APOSOR2650T-250MG)
Supplier: Apollo Scientific
Description: Chemiluminescent with antifilarial & affinity for the adenosine receptor.
UOM: 1 * 250 mg


Supplier: Thermo Scientific
Description: Apixaban

Supplier: Apollo Scientific
Description: MAPK/ERK Signalling Pathway

Supplier: Cayman Chemical
Description: Apixaban is an orally bioavailable, selective inhibitor of both free and prothrombinase-bound factor Xa (K<sub>i</sub>s = 0.8 nM).

Supplier: ENZO LIFE SCIENCES
Description: Highly potent, ATP-competitive, and specific mTOR kinase inhibitor. Antiproliferative.

New Product

Supplier: Apollo Scientific
Description: 6-Methyl-4-(trifluoromethyl)-1,6-dihydropyrazolo[3,4-c]pyrazol-3-ylamine 95+%

Supplier: Cayman Chemical
Description: WYE-125132 is an ATP-competitive inhibitor of mTOR (IC<sub>50</sub> = 0,19 nM) that inhibits signaling through both mTORC1 and mTORC2. It is selective for mTOR over phosphatidylinositol 3-kinase isoforms. WYE-125132 is effective against mTORC1 and mTORC2 in diverse cancer models, both <i>in vitro</i> and <i>in vivo</i>. Oral administration of WYE-125132 alone blocks mTOR signaling and prevents tumor growth in breast, lung, renal, and glioma cancer xenografts in mice, while combination therapy with the VEGF-inhibitor bevacizumab causes complete regression of A498 renal carcinoma tumors. In addition to its applications in cancer, WYE-125132 has been used to delineate novel aspects of mTOR signaling.

Catalog Number: (APOSOR30697-1G)
Supplier: Apollo Scientific
Description: 1H-Pyrazolo[3,4-c]pyridine 95+%
UOM: 1 * 1 g


Catalog Number: (APOSOR305393-1G)
Supplier: Apollo Scientific
Description: 3-Iodo-1H-pyrazolo[3,4-b]pyridine
UOM: 1 * 1 g


Supplier: Apollo Scientific
Description: 6-Bromo-1H-pyrazolo[3,4-b]pyridine

New Product

Inquire for Price
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us on 0800 22 33 44.
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us on 0800 22 33 44
Additional Documentation may be needed to purchase this item. A VWR representative will contact you if needed.
Additional Documentation may be needed to purchase this item. A VWR representative will contact you if needed.
This product has been blocked by your organisation. Please contact your purchasing department for more information.
The original product is no longer available. The replacement shown is available.
Product(s) marked with this symbol are discontinued - sold till end of stock. Alternatives may be available by searching with the VWR Catalogue Number listed above. If you need further assistance, please call VWR Customer Service on 0800 22 33 44.
1 - 16 of 57,391
no targeter for Bottom